编号：2022-010 证券代码：300610 证券简称：晨化股份 扬州晨化新材料股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |----------------|----------------------|---------|----------------------------| | | | | | | 投资者关系活动 | | | √特定对象调研 □分析师会议 | | 类别 | □媒体采访 | | □业绩说明会 | | | | | □新闻发布会 □路演活动 | | | □现场参观 | | | | | □其他 | | （请文字说明其他活动内容） | | 参与单位名称及 | 上海宝弘景：林 | | 珊； | | 人员姓名 | 上海宝弘景：王国语； | | | | | 中信建投： | | 叶天鸣； | | | 中信建投： | 彭 | 岩； | | | 中信建投： 周 | | 舟； | | | 中信建投： 邓 胜； | | | | | 长江证券： | 王 | 旺； | | | 银叶投资： | 曹 | 擎； | | | 歌斐资产： | 周 | 烨； | | | 菁英时代 ...

证券代码：300610 证券简称：晨化股份 扬州晨化新材料股份有限公司 投资者关系活动记录表 编号：2022-011 | --- | --- | --- | |-----------------------|---------------------------------------------------------------|---------------------------------------------------------------| | | | | | 投资者关系活动 | □特定对象调研 □分析师会议 | | | 类别 | □媒体采访 | □业绩说明会 | | | □新闻发布会 □路演活动 | | | | □现场参观 | | | | √其他（电话交流会） | | | 参与单位名称及 | | 招商资管：赵思轩；易米基金：孙会东；长城证券：王泽雷；大成基 | | 人员姓名 | 金：李本刚；长城证券：赵 何泽林；摩根士丹利华鑫基金：段一帆。 | 东；长城证券：何郭香池；东海基金： | | 时间 | 2022 年 9 月 9 日 | | | 地点 | 线上电话会议 | | | 上市公司接待 ...

编号：2022-009 证券代码：300610 证券简称：晨化股份 扬州晨化新材料股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | --- | --- | --- | |----------------|--------------------------------|--------------------------------------------------|-------|--------------------------|-------|-------| | | | | | | | | | 投资者关系活动 | | √特定对象调研 □分析师会议 | | | | | | 类别 | □媒体采访 | □业绩说明会 | | | | | | | | □新闻发布会 □路演活动 | | | | | | | □现场参观 | | | | | | | | □其他 | （请文字说明其他活动内容） | | | | | | 参与单位名称及 | 天风证券：孙潇雅；天风证券：张 | | | 欣；华泰资管：朱旭光； | | | | 人员姓名 | 鹏华基金：苏 | 东；中银国际：白冰洋；上海 ...

Financial Performance - The company's revenue for Q3 2022 was ¥246,090,982.24, a decrease of 19.32% compared to the same period last year[5]. - Net profit attributable to shareholders for Q3 2022 was ¥26,251,813.30, down 27.18% year-on-year[5]. - The basic earnings per share for Q3 2022 was ¥0.12, reflecting a decline of 29.41% compared to the previous year[5]. - Total operating revenue for the third quarter was CNY 841,653,275.98, a decrease of 9.95% compared to CNY 934,802,422.70 in the same period last year[22]. - Net profit for the period was CNY 114,524,238.28, representing a decline of 5.73% from CNY 121,348,046.93 in the previous year[23]. - Total comprehensive income for the period was CNY 114,524,238.28, compared to CNY 121,348,046.93 in the previous period, reflecting a decrease of approximately 5.5%[24]. - Basic and diluted earnings per share were both CNY 0.55, down from CNY 0.58 in the previous period, indicating a decline of about 5.2%[24]. Assets and Liabilities - Total assets at the end of Q3 2022 amounted to ¥1,330,144,889.57, representing an increase of 2.48% from the end of the previous year[5]. - The company's total assets increased to CNY 1,330,144,889.57, up from CNY 1,298,015,757.68 at the beginning of the year[21]. - Current assets totaled CNY 899,244,799.84, an increase of 4.32% from CNY 862,051,810.55[20]. - Total liabilities decreased to CNY 206,619,447.51 from CNY 226,338,562.29, a decline of 8.69%[21]. - The company's equity attributable to shareholders rose to CNY 1,101,884,145.61, an increase from CNY 1,048,094,135.30 year-on-year[21]. Cash Flow - The company reported a cash flow from operating activities of ¥99,727,028.33, which decreased by 7.86% year-to-date[5]. - Net cash flow from operating activities was CNY 99,727,028.33, a decrease of approximately 7.4% from CNY 108,230,153.55 in the previous period[26]. - Cash inflow from operating activities totaled CNY 620,690,922.52, down from CNY 654,628,353.26, representing a decline of about 5.2%[26]. - Cash outflow from operating activities was CNY 520,963,894.19, compared to CNY 546,398,199.71 in the previous period, showing a decrease of approximately 4.6%[26]. - Net cash flow from investing activities was -CNY 59,184,348.68, an improvement from -CNY 206,936,704.88 in the previous period[26]. - Cash and cash equivalents at the end of the period were CNY 42,591,120.65, down from CNY 61,335,558.99, indicating a decrease of approximately 30.5%[26]. - The company reported a cash inflow from investment activities of CNY 341,540,181.10, compared to CNY 283,468,410.87 in the previous period, reflecting an increase of about 20.5%[26]. - The company’s cash outflow from financing activities was CNY 75,362,770.46, compared to CNY 61,074,669.92 in the previous period, indicating an increase of approximately 23.4%[26]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 16,275[12]. - The largest shareholder, Yu Zizhou, holds 24.07% of shares, totaling 51,235,964 shares[12]. - The total number of restricted shares at the beginning of the period was 53,241,918, with 581,280 shares released and 15,470 shares added, resulting in 52,676,108 restricted shares at the end[14]. - The top ten shareholders hold a significant portion of shares, with the top four shareholders collectively owning over 34%[12]. - The company’s total comprehensive income attributable to the parent company was CNY 116,466,001.92, down from CNY 123,122,790.80, reflecting a decrease of about 5.4%[24]. Operational Highlights - The company experienced a significant increase in accounts receivable, which rose by 76.55% to ¥65,226,744.85, attributed to seasonal sales characteristics[10]. - The company reported a 164.91% increase in prepayments, totaling ¥36,336,267.10, mainly due to increased advance payments for materials[10]. - The company reported a significant increase in tax payable, which rose by 221.89% to ¥6,983,408.14, primarily due to increased VAT and corporate income tax[10]. - The company is focused on enhancing production efficiency and stability through automation upgrades in its production lines[15]. - The company is actively pursuing strategies for market expansion and operational improvements through its subsidiaries[15]. - The company’s subsidiary, Huai'an Chenhua, completed maintenance on its production line from August 1 to August 10, 2022, and resumed operations on August 9, 2022[16]. - The safety production license for Huai'an Chenhua was updated to allow for an annual capacity of 5,970 tons of ammonia solution, an increase from 3,500 tons[17]. - Research and development expenses increased to CNY 38,853,372.25, up 14.83% from CNY 33,997,011.03 in the previous year[23]. - The company has a stock incentive plan in place, with various executives holding restricted shares under this plan[14].

Financial Performance - The company's operating revenue for the first half of 2022 was ¥595,562,293.74, a decrease of 5.44% compared to the same period last year[24]. - Net profit attributable to shareholders increased by 3.61% to ¥90,214,188.62, while the net profit after deducting non-recurring gains and losses rose by 6.85% to ¥83,183,377.37[24]. - The net cash flow from operating activities decreased by 18.29% to ¥82,367,816.52[24]. - Total assets at the end of the reporting period reached ¥1,432,195,083.63, reflecting a growth of 10.34% compared to the end of the previous year[24]. - The company's basic and diluted earnings per share increased by 4.88% to ¥0.43[24]. - The weighted average return on equity decreased to 8.32%, down from 8.81% in the previous year[24]. - The company's operating revenue for the first half of 2022 was CNY 595.56 million, a decrease of 5.44% compared to CNY 629.80 million in the same period of 2021[61]. - The operating cost decreased by 8.78% to CNY 431.94 million from CNY 473.53 million year-on-year[61]. - The company reported a cash flow from operating activities of CNY 82.37 million, a decrease of 18.29% from CNY 100.80 million in the previous year[61]. - The company reported a revenue of 1.06 billion CNY for the first half of 2022, representing a 4.2% increase compared to the same period last year[85]. - The net profit attributable to shareholders for the first half of 2022 was 122 million CNY, which is a 28% increase year-over-year[85]. - The company reported a revenue of 4.6 billion in the first half of 2022, reflecting a year-on-year increase of 9%[86]. - The company reported a revenue of 500 million in the first half of 2022, representing a 5% increase compared to the same period last year[88]. - The company reported a revenue of 2.5 billion in the first half of 2022, representing a year-on-year increase of 4.6%[93]. - The company reported a revenue of 4.6 billion in the first half of 2022, representing a year-on-year increase of 12%[94]. - The company reported a revenue of 3.8 billion in the first half of 2022, representing a year-on-year increase of 18%[98]. Research and Development - The company has invested in R&D to strengthen its technological advantages in new materials and production processes[53]. - Research and development investment increased by 9.75% to CNY 24.72 million compared to CNY 22.52 million in the previous year[61]. - The company has allocated significant resources towards research and development, with an increase of 12% in R&D spending compared to the previous year[85]. - The company is investing 200 million in R&D for new technologies aimed at sustainability and reducing carbon footprint by 30% by 2025[87]. - Research and development expenses increased by 14% to support innovation initiatives[89]. - The company aims to increase its R&D investment by 31% in the upcoming fiscal year to drive innovation[101]. Market Expansion and Strategy - The company plans to expand its market presence and invest in new product development to drive future growth[85]. - The company plans to expand its market presence in Southeast Asia, targeting a 20% increase in market share by 2023[87]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its product offerings[85]. - The company plans to expand its market presence in Southeast Asia, targeting a 15% market share by the end of 2023[90]. - The company is considering strategic acquisitions to enhance its market position, with a budget of 300 million allocated for potential deals[95]. - The company is exploring market expansion opportunities in Southeast Asia to diversify its revenue streams[101]. Environmental Compliance and Sustainability - The company has achieved compliance with environmental standards, with emissions of non-methane total hydrocarbons at 0.002119 tons and ammonia at 0.01828 tons[132]. - The company has obtained pollution discharge permits from local environmental authorities, with the latest permit issued on August 31, 2021[133]. - The company is committed to enhancing safety management, particularly in process safety, to prevent secondary environmental incidents[134]. - The company has implemented advanced wastewater treatment processes to meet discharge standards[129]. - The company is classified as a key pollutant discharge unit by environmental authorities, indicating a focus on compliance and sustainability[129]. - The company is committed to continuous improvement in its environmental performance through technology upgrades and process optimization[129]. - The company has reported a total safety investment of 4.05 million yuan in the first half of 2022[134]. - The company has implemented a three-year action plan for safety production and risk management, aligning with provincial safety standards[134]. - The company has established a comprehensive environmental protection facility operation and maintenance management system, ensuring normal operation during the reporting period[134]. - The company is actively monitoring and managing its emissions to align with national environmental standards[129]. - The company has not experienced any major environmental pollution incidents during the reporting period[140]. Corporate Governance and Shareholder Information - The financial report is guaranteed to be true, accurate, and complete by the board of directors and management[3]. - The company has a dedicated securities affairs representative for investor inquiries[20]. - The company has not reported any changes in its registered address or contact information during the reporting period[21]. - The company did not engage in any major related party transactions during the reporting period[154]. - The company’s half-year financial report was not audited[151]. - The company held its first temporary shareholders' meeting in 2022, electing a new board of directors and supervisory board[169]. - The company approved the release of 581,280 restricted shares, reducing the total number of restricted shares to 52,676,108, which is 24.74% of the total share capital[178]. - The company’s stock incentive plan allows for the release of shares after a 24 to 36-month lock-up period for certain executives[181]. - The company has not undergone any changes in its controlling shareholder during the reporting period[189]. - The company has not issued any preferred shares during the reporting period[192]. - The company has not issued any bonds during the reporting period[195]. Risk Factors - The company faces risks from fluctuating macroeconomic conditions and market demand, which could negatively impact operational performance[111]. - The overall market demand for fine chemical new materials is expected to decrease, potentially affecting the company's performance[112]. - The company is exposed to risks from international trade tensions, particularly with the U.S., which has imposed tariffs on Chinese goods, including the company's functional silane products[117]. - The surfactant industry is experiencing increased competition, particularly in the high-margin polyether amine segment, attracting more market participants[114].

Financial Performance - The company reported a total revenue of 212,877,000 shares, with a cash dividend of 3.50 RMB per 10 shares (including tax) for all shareholders[4]. - The company's operating revenue for 2021 was ¥1,192,606,444.03, representing a 32.47% increase compared to ¥900,255,186.07 in 2020[18]. - The net profit attributable to shareholders for 2021 was ¥154,783,336.23, a 12.73% increase from ¥137,309,895.84 in 2020[18]. - The net cash flow from operating activities increased by 51.99% to ¥169,892,882.77 in 2021, up from ¥111,776,621.65 in 2020[18]. - The company's total assets as of the end of 2021 were ¥1,298,015,757.68, an increase of 11.30% from ¥1,166,236,014.48 at the end of 2020[18]. - The basic earnings per share for 2021 were ¥0.73, a 12.31% increase from ¥0.65 in 2020[18]. - The weighted average return on equity for 2021 was 15.54%, slightly up from 15.24% in 2020[18]. - The company achieved a revenue of CNY 479.12 million in 2021, which is 53.22% of the audited consolidated revenue from 2020[50]. - The total operating revenue for 2021 was ¥1,192,606,444.03, representing a year-on-year increase of 32.47% compared to ¥900,255,186.07 in 2020[65]. - The revenue from the fine chemical new materials industry accounted for 99.74% of total revenue, with a total of ¥1,189,455,370.10, up 32.59% from the previous year[65]. - The overseas revenue reached ¥199,460,429.28, a significant increase of 117.43% compared to ¥91,736,620.02 in 2020, accounting for 16.72% of total revenue[65]. Research and Development - The company focuses on R&D in fine chemical new materials, enhancing its technological advantages in the industry[29]. - The company invested 40.90 million yuan in R&D during the reporting period, with a total of 42 patents held, including 30 invention patents[58][55]. - The company has developed a range of high-temperature silicone rubber products, enhancing its competitive edge in the market[42]. - The company is in the trial production stage for several new products, including a gasoline polyether amine cleaner and a flame retardant synthesis process, aimed at enhancing product competitiveness[78]. - The company is developing a waste gas treatment solution for alkyl glycosides, which is in the trial production stage, to meet environmental requirements[79]. - The company is enhancing the performance of polyether amines to prevent yellowing in downstream products, which is currently in the small trial stage[81]. - The company is committed to enhancing its research and development capabilities to innovate new products and technologies[187]. - The company plans to enhance R&D investment in polyurethane functional additives, as the demand for polyurethane catalysts is expected to grow significantly with the industry's development[117]. Production and Operations - The company adopted a market-oriented production model, maintaining a stable production mode during the reporting period[45]. - The production capacity utilization rates for key products are: Surfactants at 79.11%, Flame Retardants at 84.14%, and Silicone Rubber at 66.82%[49]. - The company is currently constructing an additional 3,000 tons/year capacity for surfactants[49]. - The company has established a new production line with an annual capacity of 40,000 tons of polyether amines, indicating a focus on expanding production capabilities[127]. - The company is actively pursuing environmental impact assessments for new projects, with reports currently under preparation[50]. - The company has implemented a new waste gas treatment process, reducing carbon and volatile organic compound emissions[192]. Market and Sales Strategy - The company emphasizes a direct procurement model to ensure quality and control costs, maintaining a strict supplier evaluation system[44]. - The sales strategy is entirely direct sales, focusing on technical innovation and optimizing product structure to meet customer needs[46]. - The company aims to expand the production scale of surfactants, flame retardants, and polyurethane functional additives over the next three years to meet increasing market demand[116]. - The company will focus on international market expansion and strengthen brand promotion to enhance cooperation with large multinational corporations[118]. - The company is considering potential mergers and acquisitions to enhance its product portfolio and market presence[143]. Environmental Responsibility - The company has made significant investments in environmental protection, improving production processes to control and manage waste emissions effectively[126]. - The company is focused on reducing emissions and improving compliance with environmental standards as part of its operational strategy[186]. - The company has established a comprehensive emergency response plan for environmental incidents, with the latest plan filed on November 25, 2021[191]. - The company has conducted regular environmental monitoring, including emissions of VOCs, nitrogen oxides, and sulfur dioxide, as per the new discharge permit requirements[191]. - The company has not experienced any major safety or environmental incidents during the reporting period, reflecting effective safety management practices[190]. Corporate Governance - The company emphasizes investor relations management, ensuring equal access to information for all shareholders and fostering a positive image in the capital market[136]. - The board of directors consists of 9 members, including 3 independent directors, complying with legal and regulatory requirements[133]. - The company has established four specialized committees within the board, with independent directors holding a majority in each committee, enhancing decision-making quality[133]. - The company has a clear information disclosure system, with the chairman as the primary responsible person for disclosures[136]. - The company has a robust governance structure that aligns with the regulations set by the China Securities Regulatory Commission[136]. Employee Management - The company has established a competitive salary and benefits system, including various welfare policies such as subsidized housing and health check-ups[164]. - The company has established comprehensive training programs to enhance employee skills and organizational adaptability[165]. - The company reported a total of 804 employees at the end of the reporting period, with 545 in production, 113 in technology, and 46 in sales[163]. - The company has no retired employees requiring financial support, indicating a fully active workforce[163]. - The company has a total of 11 employees with postgraduate degrees, indicating a focus on skilled labor[163]. Future Outlook - Future outlook includes a projected revenue growth of 20% for 2022, driven by market expansion strategies[143]. - The company is actively pursuing new product development and market expansion strategies, particularly in the chemical industry[94]. - The company aims to continuously improve the performance evaluation and incentive mechanisms to foster shared interests between shareholders and management[176]. - The company is committed to sustainable practices and aims to minimize its environmental impact through improved emission controls[186].

Financial Performance - The company's revenue for Q1 2022 was ¥273,059,493.05, a decrease of 10.34% compared to ¥304,562,930.72 in the same period last year[3] - Net profit attributable to shareholders was ¥41,315,570.66, down 17.95% from ¥50,354,541.59 year-on-year[3] - The basic earnings per share decreased by 16.67% to ¥0.20 from ¥0.24 in the previous year[3] - Total operating revenue for Q1 2022 was CNY 273,059,493.05, a decrease of 10.4% compared to CNY 304,562,930.72 in the same period last year[16] - Net profit for Q1 2022 was CNY 40,493,126.29, a decline of 18.7% from CNY 49,766,068.29 in Q1 2021[17] - The net profit attributable to the parent company for Q1 2022 was ¥41,315,570.66, a decrease of 17.4% compared to ¥50,354,541.59 in Q1 2021[18] - The company’s total comprehensive income for Q1 2022 was ¥40,493,126.29, compared to ¥49,766,068.29 in Q1 2021, representing a decrease of 18.7%[18] Assets and Liabilities - Total assets increased by 6.45% to ¥1,381,735,829.13 from ¥1,298,015,757.68 at the end of the previous year[3] - The company's total assets as of March 31, 2022, amounted to CNY 1,381,735,829.13, an increase from CNY 1,298,015,757.68 at the beginning of the year[13] - Current assets totaled CNY 943,216,418.91, up from CNY 862,051,810.55 at the start of the year, reflecting a growth of 9.4%[12] - Total liabilities rose to CNY 266,715,542.66 from CNY 226,338,562.29, indicating an increase of 17.9%[14] - Shareholders' equity increased to CNY 1,115,020,286.47 from CNY 1,071,677,195.39, reflecting a growth of 4.0%[14] Cash Flow - The net cash flow from operating activities was ¥48,676,726.92, an increase of 2.52% compared to ¥47,480,592.19 in the same period last year[3] - Total cash inflow from operating activities was ¥179,738,104.49, compared to ¥224,311,621.79 in the previous year, indicating a decline of 19.8%[19] - Cash outflow from operating activities totaled ¥131,061,377.57, down from ¥176,831,029.60 in Q1 2021, reflecting a decrease of 25.9%[19] - The net cash flow from investing activities was -¥55,399,655.19, an improvement from -¥174,922,726.29 in the same period last year[21] - The cash and cash equivalents at the end of Q1 2022 were ¥67,851,976.65, compared to ¥52,875,611.27 at the end of Q1 2021, showing an increase of 28.3%[21] - The company reported cash inflow from other investment activities of ¥118,151,169.44 in Q1 2022[21] - The total cash outflow from investing activities was ¥173,550,824.63, down from ¥283,161,269.34 in Q1 2021[21] Operational Metrics - The weighted average return on equity decreased to 3.86% from 5.15% year-on-year, a decline of 1.29%[3] - Accounts receivable increased by 119.25% to ¥81,005,689.26 from ¥36,945,885.96 at the end of the previous year, mainly due to seasonal characteristics of business activities[8] - The company reported a significant increase in prepayments by 71.96% to ¥23,586,981.29, attributed to higher material prepayments[8] - The company experienced a 6138.38% increase in non-operating expenses, amounting to ¥5,494,952.65, primarily due to temporary production line shutdowns[8] - Total operating costs for Q1 2022 were CNY 231,543,723.69, down 10.9% from CNY 259,931,567.69 in Q1 2021[17] - Research and development expenses for Q1 2022 were CNY 13,204,159.61, up from CNY 10,301,078.18 in Q1 2021, indicating a 28.0% increase[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 17,016[10] - The basic and diluted earnings per share for Q1 2022 were both ¥0.20, down from ¥0.24 in the same period last year[18]

Financial Performance - The company's revenue for Q3 2021 reached ¥305,006,576.37, representing a year-on-year increase of 29.68%[3] - The net profit attributable to shareholders decreased by 10.97% to ¥36,052,651.21 for the same period[3] - The net profit after deducting non-recurring gains and losses was ¥30,381,163.83, down 13.59% year-on-year[3] - The basic earnings per share for Q3 2021 was ¥0.1709, a decrease of 11.17% compared to the same period last year[3] - The total operating revenue for the third quarter was CNY 934,802,422.70, an increase from CNY 619,358,290.64 in the previous period[23] - The net profit for the quarter reached CNY 121,348,046.93, up from CNY 93,919,788.13 year-over-year, indicating a growth of approximately 29.2%[24] - Earnings per share (EPS) increased to CNY 0.5842 from CNY 0.4559, representing a growth of about 28.2%[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,350,172,143.91, an increase of 15.77% compared to the end of the previous year[3] - As of September 30, 2021, total assets reached CNY 1,350,172,143.91, an increase from CNY 1,166,236,014.48 at the end of 2020, reflecting a growth of approximately 15.7%[19] - The company's current assets amounted to CNY 912,878,587.67, up from CNY 783,641,666.28, indicating a growth of about 16.5% year-over-year[20] - The total liabilities increased to CNY 307,290,783.92 from CNY 186,534,351.56, reflecting a rise in financial obligations[24] - The total liabilities as of September 30, 2021, were not explicitly stated but included short-term borrowings of CNY 30,000,000.00, a significant increase from CNY 100,036.25 previously[20] Cash Flow - The company's operating cash flow for the year-to-date was ¥108,230,153.55, up 58.19%[3] - The cash flow from operating activities generated a net amount of CNY 108,230,153.55, compared to CNY 68,415,916.74 in the previous period, showing a substantial increase[27] - The net cash flow from investment activities was -206,936,704.88 CNY, compared to -242,082,012.00 CNY in the previous year, indicating an improvement of approximately 14.4%[28] - Cash inflow from financing activities totaled 41,009,984.00 CNY, an increase from 34,200,500.00 CNY year-over-year, representing a growth of about 19.5%[28] - The ending balance of cash and cash equivalents was 61,335,558.99 CNY, a significant decrease from 14,871,330.86 CNY year-over-year[28] Research and Development - Research and development expenses for the first nine months were ¥33,997,011.03, reflecting a 52.85% increase due to enhanced project efforts[10] - Research and development expenses for the quarter were CNY 33,997,011.03, up from CNY 22,242,645.35, indicating a focus on innovation[23] - A framework agreement for comprehensive technical cooperation was signed with the China Daily Chemical Research Institute, enhancing R&D capabilities[16] Production and Operations - The company entered trial production for the 10,000 tons/year terminal amino polyether project and the 22,700 tons/year polyether project, both part of the Huai'an production base[16] - The company faced temporary production halts due to government-mandated power restrictions but resumed operations on October 8, 2021[17] - A cooperation framework agreement was established for a new project with an annual output of 40,000 tons of polyether amine and 42,000 tons of polyether[17] Shareholder Equity - The total equity attributable to shareholders reached CNY 1,019,087,166.01, compared to CNY 954,132,725.07 in the previous period, showing a growth in shareholder value[24] - The company reported a total of 457,519 restricted shares, with 372,400 shares released during the period, indicating active management of executive stock incentives[15] Other Financial Metrics - The total operating costs amounted to CNY 827,599,855.77, compared to CNY 538,690,251.68 in the prior period, reflecting a significant rise in costs[23] - The deferred income decreased slightly to CNY 34,309,443.29 from CNY 35,215,182.23, indicating stability in future revenue recognition[24] - The cash inflow from investment activities was 283,468,410.87 CNY, compared to 242,704,124.33 CNY in the previous year, marking an increase of approximately 16.8%[28] Audit and Reporting - The company did not undergo an audit for the third quarter report[30] - The report was released on October 26, 2021, and is the first to apply the new leasing standards[29]

Financial Performance - The company reported a revenue of 300 million RMB for the first half of 2021, representing a 15% increase compared to the same period last year[15]. - The net profit attributable to shareholders was 50 million RMB, up 20% year-on-year[15]. - The company's operating revenue for the reporting period was ¥629,795,846.33, representing a year-on-year increase of 63.94% compared to ¥384,161,882.39 in the same period last year[21]. - The net profit attributable to shareholders was ¥87,070,139.58, up 57.17% from ¥55,398,849.73 in the previous year[21]. - The basic earnings per share increased to ¥0.54, a rise of 45.95% compared to ¥0.37 in the same period last year[21]. - The company reported a total profit of ¥99,279,955.90 for the first half of 2021, up 61.3% from ¥61,519,725.92 in the same period of 2020[193]. - The company reported a revenue of 500 million for the first half of 2021, reflecting a year-on-year growth of 10% compared to the same period in 2020[81]. - The company reported a revenue of 1,500 million with a growth rate of 3.90% for the first half of 2021[83]. - The company reported a total revenue of 59,500 million with a net profit of 1,721 million, reflecting a significant performance in the first half of 2021[89]. Research and Development - The company plans to invest 10 million RMB in R&D for new product development in the next fiscal year[15]. - The company is developing new eco-friendly materials, with a projected launch date in Q4 2021[15]. - The company's R&D investment increased by 109.32% to ¥22,524,970.62, up from ¥10,761,029.07, reflecting enhanced efforts in research projects[53]. - The company has a professional R&D team of 96 members, enabling timely product development in response to market demands[50]. - The company is investing in research and development, allocating 300 million for new technology initiatives[84]. Market Expansion and Strategy - The company has outlined a market expansion strategy targeting Southeast Asia, aiming for a 30% market share by 2025[15]. - The company plans to expand its market presence by launching new products in the second half of 2021, targeting a 15% increase in market share[82]. - The company is focusing on expanding its market share in the Asia-Pacific region[86]. - The company is exploring potential mergers and acquisitions to enhance its growth strategy[86]. Financial Management and Investments - The total amount of raised funds is CNY 2,182.2 million, with CNY 293.41 million invested during the reporting period[68]. - The company has engaged in entrusted financial management, with a total of CNY 30 million in financial products, including CNY 27.5 million from self-owned funds and CNY 2.5 million from raised funds[77]. - The company has a total of 177.67 million CNY in realized gains from its financial investments during the reporting period[78]. - The company is committed to maintaining a diversified investment portfolio to mitigate risks associated with market fluctuations[79]. Environmental and Safety Compliance - The company is committed to maintaining compliance with environmental regulations and standards[114]. - The company has implemented a wastewater treatment system to ensure compliance with discharge standards[114]. - The company has established an emergency response plan for environmental incidents, which has been reviewed and filed[119]. - The company has not experienced any major safety or environmental incidents during the reporting period[119]. Shareholder and Corporate Governance - The company held three shareholder meetings during the reporting period, with investor participation rates of 40.32%, 44.66%, and 39.42% respectively[104][105]. - The company plans not to distribute cash dividends or issue bonus shares for the half-year period[106]. - The company approved a restricted stock incentive plan, granting 1,937,600 shares to 96 individuals[159]. - The company confirmed the retirement of a key technical personnel, ensuring a smooth transition without negative impact on R&D or operations[153]. Risk Factors - The company faces risks from the COVID-19 pandemic and macroeconomic fluctuations, which could lead to reduced downstream demand and overcapacity, negatively impacting profitability[95]. - The company is exposed to international trade friction risks, particularly with the U.S., which has imposed tariffs on Chinese goods, potentially affecting the export of its functional silane products[99]. - Environmental protection and safety risks are significant, as the company deals with hazardous materials, and any incidents could adversely affect operations and compliance with increasing environmental standards[98].

Financial Performance - The company's revenue for Q1 2021 was CNY 304,562,930.72, representing an increase of 81.86% compared to CNY 167,469,781.07 in the same period last year[7]. - Net profit attributable to shareholders was CNY 50,354,541.59, a significant increase of 154.75% from CNY 19,765,999.98 year-on-year[7]. - The net profit after deducting non-recurring gains and losses reached CNY 45,639,469.20, up 166.03% from CNY 17,155,912.79 in the previous year[7]. - The basic earnings per share (EPS) was CNY 0.33, reflecting a growth of 153.85% compared to CNY 0.13 in the same quarter last year[7]. - The total operating revenue for the first quarter of 2021 reached ¥304,562,930.72, compared to ¥167,469,781.07 in the previous period, representing an increase of approximately 81.8%[47]. - Net profit for the first quarter was ¥49,766,068.29, compared to ¥19,597,029.46 in the same period last year, reflecting an increase of approximately 153.5%[49]. - The company reported a total profit of ¥54,284,280.97 for the first quarter, compared to ¥22,066,634.75 in the previous year, an increase of approximately 145.0%[49]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,308,317,274.11, an increase of 12.18% from CNY 1,166,236,014.48 at the end of the previous year[7]. - The company's total assets as of March 31, 2021, were ¥1,134,925,791.67, up from ¥1,039,972,779.00 at the end of 2020, marking an increase of about 9.1%[44]. - The total liabilities of the company were CNY 281,020,536.77 as of March 31, 2021, compared to CNY 186,534,351.56 at the end of 2020, which is an increase of approximately 50.5%[40]. - Current liabilities increased to ¥175,440,358.20 from ¥107,881,363.74, representing a growth of approximately 62.5%[45]. Cash Flow - The net cash flow from operating activities was CNY 47,480,592.19, showing a 10.58% increase from CNY 42,938,338.62 in the same period last year[7]. - The cash flow from operating activities generated a net amount of ¥47,480,592.19, up from ¥42,938,338.62 in the previous period, reflecting a growth of approximately 12%[57]. - The company's cash and cash equivalents decreased to CNY 52,875,611.27 from CNY 180,416,364.93, a decline of approximately 70.7%[37]. - The ending balance of cash and cash equivalents was ¥41,668,452.61, down from ¥159,848,738.46 at the beginning of the period[61]. Research and Development - Research and development expenses increased by 89.19% to ¥10.30 million in Q1 2021, driven by an increase in the number and progress of R&D projects[16]. - The company has 26 ongoing R&D projects aimed at optimizing existing products and developing new ones[17]. - The company plans to invest in expanding its R&D capabilities to enhance product innovation and maintain competitive advantage[21]. - Research and development expenses for the first quarter were ¥10,301,078.18, up from ¥5,444,880.23, indicating an increase of approximately 89.5%[48]. Investments and Fundraising - The company reported a total fundraising amount of 21,822 million yuan, with 631.74 million yuan invested in the current quarter[27]. - Cumulative investment from fundraising reached 14,907.94 million yuan, with 18.36% of the funds having been repurposed[27]. - The project for producing 15,000 tons of alkyl glycosides has achieved 90.46% of its investment target, totaling 5,337.4 million yuan[27]. - The total investment for the R&D building project has increased from 40.06 million to 109.18 million, with 40.06 million sourced from previous fundraising and 69.12 million from company self-funding[28]. Risks and Challenges - Risks include intensified industry competition and potential quality control issues, which could adversely affect business operations and reputation[20]. - The company faces risks related to the transportation of hazardous chemicals, which could impact raw material supply and daily operations[22]. - The retirement of a core technical staff member may affect the company's technological capabilities[23]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,317[11]. - The company has not reported any overdue commitments from major stakeholders during the reporting period[25]. - There are no non-operational fund occupations by controlling shareholders or related parties reported during the period[31]. Corporate Governance - The company has successfully renewed its high-tech enterprise certification, allowing it to continue enjoying a 15% corporate income tax rate until 2022[23]. - The company has not reported any violations regarding external guarantees during the reporting period[30]. - The company has conducted investor relations activities, discussing operational conditions and market management with institutional investors[32].